Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.

To the best of our knowledge, no previous reports have suggested that prolonged time from symptom onset to initial antiviral treatment might be a risk factor for severe COVID-19 in KTRs during the Omicron subvariant-dominant periods, which suggests that our results may be significant.

also in 13,097 other papers